Effects of nicotine nasal spray on cognitive function in schizophrenia.
about
Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption.Tobacco use among individuals with schizophrenia: what role has the tobacco industry played?Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophreniaA reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists.Cigarette Cravings, Impulsivity, and the BrainVarenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized TrialCigarette smoking and cognitive function in Chinese male schizophrenia: a case-control studyLong-term improvements in sensory inhibition with gestational choline supplementation linked to α7 nicotinic receptors through studies in Chrna7 null mutation mice.Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patientsEvaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia.Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia.Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptorEffects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.Mouse pharmacological models of cognitive disruption relevant to schizophrenia.Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophreniaNicotine, Auditory Sensory Memory, and sustained Attention in a Human Ketamine Model of Schizophrenia: Moderating Influence of a Hallucinatory Trait.Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking statusfMRI data predict individual differences of behavioral effects of nicotine: a partial least square analysis.Predictors of early abstinence in smokers with schizophreniaGender differences in the association between pre-adolescent smoking initiation and emotional or behavioural problems.The effects of galantamine on psychopathology in chronic stable schizophrenia.Alpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration.The effect of odor valence on olfactory performance in schizophrenia patients, unaffected relatives and at-risk youth.Anxiolytic effects of the MCH1R antagonist TPI 1361-17.The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study.Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophreniaInitial phase 2 trial of a nicotinic agonist in schizophrenia.Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.Cognitive effects of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controlsNicotine improves working memory span capacity in rats following sub-chronic ketamine exposureCancer 'survivor-care': I. the α7 nAChR as potential target for chemotherapy-related cognitive impairment.Long term effects of smoking cessation in hospitalized schizophrenia patients.Methods for treating cognitive deficits in schizophrenia.Cholinergic circuits and signaling in the pathophysiology of schizophreniaRecent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia.Social defeat stress in rats: escalation of cocaine and "speedball" binge self-administration, but not heroin.Comparison of the effectiveness of Conners' CPT and the CPT-identical pairs at distinguishing between smokers and nonsmokers with schizophrenia.Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia.Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia.Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration.
P2860
Q21129280-E181D16A-8F22-4ECD-BFB2-51E13DBBB2D6Q24643892-6EB24F2C-F9B3-4304-A9DB-83C5CC5DB95DQ24646206-5ACDE420-8047-4A3A-AEE9-F1AD6747CB6DQ24650678-4337DACD-A69A-4E27-AE88-26B0DBE46782Q26781531-C5213B02-A1AD-487D-996A-9F7DDBED6877Q28552053-B75DEF19-FB14-452B-9AE7-93CA65DD3637Q28730147-73C4B008-0BE7-4623-AA76-AC2421A3A7B7Q30413798-86364985-12E7-4D94-BAF2-C74820A7E5D2Q30425458-9F99DCFE-D608-4B31-B9E4-FD7396EB49D9Q30428422-BC3A6BC1-E178-48E2-8469-852D511C0428Q30435496-D18FEE2C-5A9A-413E-A5DF-44C8B07A0BE1Q30453198-022CA462-B167-4FC9-9367-4AF57AA306FBQ30455599-11649013-5BCB-400D-9FE9-3D2608838D5DQ30457807-D97CBB94-AA28-4CE8-8E18-CFE18F137BF7Q30459624-13DEB1F8-96F7-4FA6-8521-4CB2D39F5050Q30462575-03890FC0-C18A-4280-8553-61C543F62A5EQ30479419-FD3C9292-C55F-4F85-8295-4AD67001C504Q31106729-32EED1D8-560A-4A5D-8525-DB1DEF9F7E5BQ33679772-F6DF33CD-B726-420B-88CF-0BEF22F2140AQ33721332-77796C9D-CE13-41EE-9CEF-12FCE7E9F16AQ33724801-62931DF9-9FC5-45A6-86D1-529FCD7BAA5FQ33955075-1F53DAA4-0362-4B68-82C0-3B61F5513389Q34344448-63D9CD38-3959-483B-A8D4-520D0794514AQ34520075-F547F999-505F-4B4C-B8B7-31BC66BEE90AQ34531316-D13F6E36-C017-40F0-BBD7-7EC869D11341Q34604413-26A95190-7B8E-461F-B0C1-B81AF0956BC2Q34766663-2A2AA3F7-1B2E-44FF-96D8-E9FA173E504CQ35048154-BA576FA9-1B93-4002-AFAD-A4452925DC05Q35473864-D07C5521-59CD-4FAC-BF88-5974773F9F50Q35592077-A788832E-B05A-40D0-9459-E4768B9B898AQ35646004-C872D4ED-8557-44A6-825D-B4C340033119Q36300051-4E3A828A-B773-428C-815E-6CDCD9359822Q36752922-C98FE8FD-C36F-41CB-8760-3855C9554F81Q36756379-E392FFEE-FAF1-4FEF-9F60-BA26E0446D25Q36886717-027949C3-D7FA-4084-A863-15AA3C9DC7D2Q36998925-09D07D08-21A8-4576-9E72-BA080D719CBFQ37067243-BBDED49A-5F8B-4785-88AD-301B7A2C1332Q37076356-E7D78043-BD39-4DA1-9F6C-FE82346EBC49Q37079797-080A87CF-CF69-438F-A576-4F9C6324D8A7Q37081349-FA4107C1-D24E-4873-AAC6-5987D573BB93
P2860
Effects of nicotine nasal spray on cognitive function in schizophrenia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Effects of nicotine nasal spray on cognitive function in schizophrenia.
@en
Effects of nicotine nasal spray on cognitive function in schizophrenia.
@nl
type
label
Effects of nicotine nasal spray on cognitive function in schizophrenia.
@en
Effects of nicotine nasal spray on cognitive function in schizophrenia.
@nl
prefLabel
Effects of nicotine nasal spray on cognitive function in schizophrenia.
@en
Effects of nicotine nasal spray on cognitive function in schizophrenia.
@nl
P2093
P2860
P356
P1476
Effects of nicotine nasal spray on cognitive function in schizophrenia.
@en
P2093
Erin Butler
Erin Kelly
Jessy Warner-Cohen
Melissa Matute
Robert C Smith
Sumathi Vaidhyanathaswamy
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300881
P407
P577
2006-03-01T00:00:00Z